Luis Malave

CIK: 0001395781

Transaction Breakdown

Open Market Buys (P)1 (5.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)15 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (11.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GCTK

Glucotrack, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (18 total)

GCTK
Glucotrack, Inc.
Oct 3, 2025
Award(A)
Direct
463 shares-
GCTK
Glucotrack, Inc.
Jul 11, 2025
Award(A)
Direct
1.2K shares-
GCTK
Glucotrack, Inc.
Mar 26, 2025
Award(A)
Direct
2.1K shares-
GCTK
Glucotrack, Inc.
Mar 25, 2025
Award(A)
Direct
35 shares-
GCTK
Glucotrack, Inc.
Mar 12, 2025
In-the-Money(X)
Direct
133.5K shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Award(A)
Series B Common Warrant
Direct
6.9K shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Conversion(C)
Direct
6.9K shares at avg. $31.20$215K
GCTK
Glucotrack, Inc.
Nov 14, 2024
Award(A)
Series A Common Warrant
Direct
6.9K shares-
GCTK
Glucotrack, Inc.
Jul 18, 2024
Purchase(P)
Convertible Promissory Note
Direct
0 shares at avg. $200000.00-
GCTK
Glucotrack, Inc.
Apr 8, 2024
Award(A)
Direct
489 shares-
GCTK
Glucotrack, Inc.
Dec 31, 2023
Award(A)
Direct
362 shares-
GCTK
Glucotrack, Inc.
Apr 20, 2023
Award(A)
Direct
121 shares-
GCTK
Glucotrack, Inc.
Jan 9, 2023
Award(A)
Direct
29 shares-
GCTK
Glucotrack, Inc.
Oct 4, 2022
Award(A)
Direct
44 shares-
GCTK
Glucotrack, Inc.
Jun 30, 2022
Award(A)
Direct
34 shares-
GCTK
Glucotrack, Inc.
Mar 31, 2022
Award(A)
Direct
25 shares-
GCTK
Glucotrack, Inc.
Dec 31, 2021
Award(A)
Direct
11 shares-
GCTK
Glucotrack, Inc.
Sep 30, 2021
Award(A)
Direct
8 shares-

		Type	Shares	Price		Ownership
Oct 3, 2025	GCTK Glucotrack, Inc.	Award(A)	463	-	-	Direct
Jul 11, 2025	GCTK Glucotrack, Inc.	Award(A)	1,200	-	-	Direct
Mar 26, 2025	GCTK Glucotrack, Inc.	Award(A)	2,076	-	-	Direct
Mar 25, 2025	GCTK Glucotrack, Inc.	Award(A)	35	-	-	Direct
Mar 12, 2025	GCTK Glucotrack, Inc.	In-the-Money(X)	133,532	-	-	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Award(A) Series B Common Warrant	6,886	-	-	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Conversion(C)	6,886	$31.20	$214,843	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Award(A) Series A Common Warrant	6,886	-	-	Direct
Jul 18, 2024	GCTK Glucotrack, Inc.	Purchase(P) Convertible Promissory Note	0	$200000.00	-	Direct
Apr 8, 2024	GCTK Glucotrack, Inc.	Award(A)	489	-	-	Direct
Dec 31, 2023	GCTK Glucotrack, Inc.	Award(A)	362	-	-	Direct
Apr 20, 2023	GCTK Glucotrack, Inc.	Award(A)	121	-	-	Direct
Jan 9, 2023	GCTK Glucotrack, Inc.	Award(A)	29	-	-	Direct
Oct 4, 2022	GCTK Glucotrack, Inc.	Award(A)	44	-	-	Direct
Jun 30, 2022	GCTK Glucotrack, Inc.	Award(A)	34	-	-	Direct
Mar 31, 2022	GCTK Glucotrack, Inc.	Award(A)	25	-	-	Direct
Dec 31, 2021	GCTK Glucotrack, Inc.	Award(A)	11	-	-	Direct
Sep 30, 2021	GCTK Glucotrack, Inc.	Award(A)	8	-	-	Direct

1-18 of 18 transactions

About Malave Luis

Malave Luis (SEC CIK 0001395781) files insider reports with the SEC as Director of Glucotrack, Inc. (GCTK).

Signal8 holds 3 ownership filings by Malave Luis (1 Form 3, 2 Form 4), filed between Mar 28, 2025 and Oct 7, 2025. Those filings report 18 transactions, from Sep 30, 2021 to Oct 3, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Malave Luis's filings is in RUTHERFORD, NJ.

Recent filings by Malave Luis

Oct 3, 2025: Grant or award of GCTK shares (Form 4, code A).
Jul 11, 2025: Grant or award of GCTK shares (Form 4, code A).
Mar 26, 2025: Grant or award of GCTK shares (Form 4, code A).
Mar 25, 2025: Grant or award of GCTK shares (Form 4, code A).
Mar 12, 2025: Option exercise of GCTK shares (Form 4, code X).

Other insiders filing for Glucotrack, Inc. (GCTK)

CARR BRENDEL VICTORIA, Director
Balo Andrew K, Director
Carter Erin Catherine, Director
Goode Paul, Chief Executive Officer
John A. Ballantyne Revocable Living Trust dated 08/01/2017, 10% Owner
BALLANTYNE JOHN, Director

How to read Form 4 transaction codes